SOHO Highlights: State of the Art and Next Questions

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

SOHO Highlights: State of the Art and Next Questions

2023
2022
2021
Event

CML State of the Art: Dasatinib/Imatinib Dose Optimization, STAMPi Asciminib Efficacy in CP-CML, Treatment Free Remission, Single Cell Analysis

By SOHO Highlights: State of the Art and Next Questions FEATURING Michael Deininger

65 views

February 5, 2021

Comments 0

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Moving Forward in Stage III/IV Classical Hodgkin Lymphoma

Feat. A. Ip

2021

Newly Diagnosed ALCL/PTCL State of the Art: How Can We Improve Outco…

SOHO Highlights: State of the Art and Next Questions

K. Savage

129 views

SOHO Updates on 1L FL: Does RT+/-(R)CVP Improve PFS in Limited Stage…

SOHO Highlights: State of the Art and Next Questions

R. Marcus

117 views

SOHO Highlights on Non-Bulky cHL: Can We Treat Early Disease With Sh…

SOHO Highlights: State of the Art and Next Questions

D. Straus

23 views

ECHELON-1 Data on Brentuximab Vedotin for Frontline Advanced cHL: Ex…

SOHO Highlights: State of the Art and Next Questions

D. Straus

292 views

Surveying the Induction and Maintenance Therapy Landscape in Newly D…

SOHO Highlights: State of the Art and Next Questions

S. Lonial

243 views

MM State of the Art: Approaches to Smoldering, MRD as a Prognostic M…

SOHO Highlights: State of the Art and Next Questions

S. Lonial

34 views

CML State of the Art: Dasatinib/Imatinib Dose Optimization, STAMPi A…

SOHO Highlights: State of the Art and Next Questions

M. Deininger

65 views

MPNs State of the Art: What Is the Response to Ruxolitinib vs. BAT? …

SOHO Highlights: State of the Art and Next Questions

S. Verstovsek

166 views

MDS State of the Art: Imetelstat/Roxadustat for Anemia, Oral HMAs, A…

SOHO Highlights: State of the Art and Next Questions

G. Garcia-Manero

135 views

Early Stage cHL Management: Bulky vs. Non-bulky Disease, Better Chem…

SOHO Highlights: State of the Art and Next Questions

D. Straus

174 views

SOHO Highlights on Untreated MCL: How Does Deferred Therapy Work? Wh…

SOHO Highlights: State of the Art and Next Questions

J. Cohen

95 views

SOHO Highlights on R/R MCL: The Role of BTKis, CAR-T, and Chemothera…

SOHO Highlights: State of the Art and Next Questions

J. Cohen

156 views

R/R PTCL State of the Art: Allo-SCT vs. Auto-SCT? Can Pralatrexate C…

SOHO Highlights: State of the Art and Next Questions

K. Savage

23 views

SOHO Updates on 1L MZL: Can RT Help in Early Stage MALToma? Is R-Ben…

SOHO Highlights: State of the Art and Next Questions

R. Marcus

22 views

DLBCL State of the Art: Does Gene Expression Help With the Disease? …

SOHO Highlights: State of the Art and Next Questions

S. Dave

123 views

Dana-Farber CLL State of the Art: A Review of BTK Inhibitors Data in…

SOHO Highlights: State of the Art and Next Questions

J. Brown

227 views

CAR-T State of the Art: What Therapies Will Be Available in the Next…

SOHO Highlights: State of the Art and Next Questions

S. Giralt

40 views

AML State of the Art: Older Patients Management, MRD, Total Oral Com…

SOHO Highlights: State of the Art and Next Questions

A. Zeidan

124 views

ALL State of the Art at MD Anderson: Hyper-CVAD Combinations, MiniHC…

SOHO Highlights: State of the Art and Next Questions

H. Kantarjian

39 views